
Reasons why patients fail screening in Indian breast cancer trials
Author(s) -
Pratiksha Mahajan,
Apoorva Kulkarni,
Sriniwas B Narayanswamy,
Jignesh Dalal,
Vipul Halbe,
Shraddha Patkar,
Amit Bhatt
Publication year - 2015
Publication title -
perspectives in clinical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.649
H-Index - 8
eISSN - 2229-5488
pISSN - 2229-3485
DOI - 10.4103/2229-3485.167100
Subject(s) - medicine , clinical trial , informed consent , breast cancer , patient recruitment , protocol (science) , cancer , alternative medicine , pathology
An increased number of screen failure patients in a clinical trial increases time and cost required for the recruitment. Assessment of reasons for screen failure can help reduce screen failure rates and improve recruitment.